AbbVie Announces Topline Results for Epcoritamab (DuoBody® CD3xCD20) from Phase 3 EPCORE® DLBCL-1 Trial in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)

AbbVie (NYSE: ABBV) today announced topline results from the Phase 3 EPCORE® DLBCL-1 trial evaluating epcoritamab, a T-cell engaging bispecific antibody administered subcutaneously, compared to ...

Chevron and partners approve Leviathan expansion to boost Israel gas output

The Final Investment Decision aims to increase capacity to approximately 21 BCM annually through new wells and platform ...
OilPrice.com

Chevron Approves Leviathan Gas Expansion in Eastern Mediterranean

Chevron has taken a final investment decision to expand production at Israel’s Leviathan gas field, significantly increasing ...
Scientific Research Publishing

Comparative Study of Vaginal Microecological Characteristics in Populations with Different Disease Types ()

Objective: To compare and analyze the differences in vaginal microecological characteristics between populations with ...